TCL Archive NCI, NHGRI plan $100-million, three-year feasibility test for cancer genome project. NCI to establish biospecimen office. September 23, 2005
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level March 7, 2014
